Open access · CC-BY
via OpenAlex
Emerging Role of Sirtuin 2 in Parkinson’s Disease
Yumei Liu, Yingying Zhang, Konghua Zhu, Song Chi, Chong Wang, Anmu Xie
Frontiers in Aging Neuroscience · 2020 · ▲ 91 citations
Epigenetic alterations
Deregulated nutrient-sensing
Chronic inflammation
Disabled macroautophagy
Review
Abstract
Parkinson's disease (PD), the main risk factor of which is age, is one of the most common neurodegenerative diseases, thus presenting a substantial burden on the health of affected individuals as well as an economic burden. Sirtuin 2 (SIRT2), a subtype in the family of sirtuins, belongs to class III histone deacetylases (HDACs). It is known that SIRT2 levels increase with aging, and a growing body of evidence has been accumulating, showing that the activity of SIRT2 mediates various processes involved in PD pathogenesis, including aggregation of α-synuclein (α-syn), microtubule function, oxidative stress, inflammation, and autophagy(definition). There have been conflicting reports about the role of SIRT2 in PD, in that some studies indicate its potential to induce the death of dopaminergic (DA) neurons, and that inhibition of SIRT2 may, therefore, have protective effects in PD. Other studies suggest a protective role of SIRT2 in the context of neuronal damage. As current treatments for PD are directed at alleviating symptoms and are very limited, a comprehensive understanding of the enzymology of SIRT2 in PD may be essential for developing novel therapeutic agents for the treatment of this disease. This review article will provide an update on our knowledge of the structure, distribution, and biological characteristics of SIRT2, and highlight its role in the pathogenesis of PD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fnagi.2019.00372
- Canonical
- link ↗
- Fetched
- 2026-07-27 MST
Cite this
APA
Liu, Y., Zhang, Y., Zhu, K., Chi, S., Wang, C., & Xie, A. (2020). Emerging Role of Sirtuin 2 in Parkinson’s Disease. <em>Frontiers in Aging Neuroscience</em>. https://doi.org/10.3389/fnagi.2019.00372
Vancouver
Liu Y, Zhang Y, Zhu K, Chi S, Wang C, Xie A. Emerging Role of Sirtuin 2 in Parkinson’s Disease. Frontiers in Aging Neuroscience. 2020. doi:10.3389/fnagi.2019.00372.
BibTeX
@article{yumei2020Emergi,
title = {Emerging Role of Sirtuin 2 in Parkinson’s Disease},
author = {Yumei Liu and Yingying Zhang and Konghua Zhu and Song Chi and Chong Wang and Anmu Xie},
journal = {Frontiers in Aging Neuroscience},
year = {2020},
doi = {10.3389/fnagi.2019.00372},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Neuroscience 2019
Open access · CC-BY
The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson’s Diseases
Trends in molecular medicine 2026
Citation only
Telomerase reverse transcriptase as a core regulator of brain health.
International Journal of Molecular Sciences 2023
Open access · CC-BY
Oxidative Stress and Aging as Risk Factors for Alzheimer’s Disease and Parkinson’s Disease: The Role of the Antioxidant Melatonin
Current Neuropharmacology 2018
Open access · OA
Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy
Aging and Disease 2020
Open access · CC-BY
The Critical Role of SIRT1 in Parkinson’s Disease: Mechanism and Therapeutic Considerations
Cold Spring Harbor Perspectives in Medicine 2012
Preprint · OA